Application of Machine Learning in Healthcare

COVID-19 transformed how we collectively delivered care in 2020. Not only are we seeing an upending of traditional health care settings, but patients increasingly expect to know the costs of their care ahead of time.

Biosimilars have the potential to deliver significant cost savings across healthcare. As this emerging market evolves, the product landscape faces significant hurdles. In order to ensure success

It is with great pleasure that I invite you to participate in the ESMO Webinar entitled ‘Translating Immunity to Clinical Applications of Immunotherapy in Breast Cancer’. This webinar will go live on 3 May from ESMO Breast Cancer 2019 in Berlin.Breast cancer has traditionally been considered as an immunologically silent disease. However, recent preclinical and clinical research suggests that immunotherapy can improve outcomes in a subset of breast cancer patients.I am delighted to announce the lectures by three distinguished experts in the field who will join me in this webinar.

Join in a practical review of validated geriatric assessment tools and learn how to incorporate them into your oncology practice. Logistics, including who can and should administer the assessment will also be included.